Stock ALNHT NH THERAGUIX SAS
Add to a list
To use this feature you must be a member
Log inSign up

All News NH TherAguix SAS

Equities

ALNHT

FR0013105954

Market Closed - Euronext Paris
Other stock markets
 20:34:17 2021-10-21 EDT 		5-day change 1st Jan Change
0.01 EUR -.--% Intraday chart for NH TherAguix SAS -.--% -.--%
2021 NH TherAguix SAS and Carbogen AMCIS AG Announce the Release of New Batch of AGuIX Drug Product for Clinical Trials CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NH TherAguix SAS : announces the publication of promising preclinical results of AGuIX® in combination with targeted radioligand therapies (TRT)
PU
NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer
PU
NH TherAguix SAS : announces communications to be presented at the AAPM meeting by Harvard Medical Schools collaborators
PU
NH TherAguix SAS : announces the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence
PU
NH TherAguix SAS : announces the thesis defense of Dr. Paul Rocchi as the first NHT-funded PhD student
PU
NH TherAguix SAS and Carbogen AMCIS AG Announce the Release of New Batch of AGuIX Drug Product for Clinical Trials
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALNHT Stock
  4. News NH TherAguix SAS
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW